News Focus: Chemical M&A activity continues to fall

21 May 2012 00:00  [Source: ICB]

We have maintained since autumn 2011 that the global chemical mergers and acquisitions (M&A) market had already peaked and would continue to fall.

Tied hands, Rex Features

Rex Features

M&A activity is all tied up

Recent evidence has borne this out, contrary to the bullish statements of others.

One investment banker went as far as to predict that the M&A market in 2012 would continue to be strong and improve on 2011.

Young & Partners believes that the chemical M&A market is clearly past the peak that occurred early last autumn - both in terms of dollar volumes and in valuations - as greater uncertainty about the economic outlook and a more difficult high yield financing market has restrained transactions.

Although strategic buyers are under pressure to grow, they also are being cautious in an uncertain economic environment.

During almost every conversation that we have had with chemical industry CEOs, they have mentioned their concerns about the health of the banks in Europe, the economic situation in Europe, and slowing growth in Asia.

Although total M&A deal ­volume was strong through the first three quarters of 2011, deal activity in terms of dollar volume began to slow down in the fourth quarter.

Fewer large deals have been announced and the only decent-sized deal that has been announced in 2012 is US-based Eastman Chemical's planned acquisition of US-based chemical and materials company Solutia for $4.7bn (€3.7bn).

FEWER OPEN DEALS

Perhaps the most tangible ­evidence of the slowdown is in the number and dollar volume of deals announced but not closed - the best measure of the M&A pipeline.

This has fallen almost every quarter since the end of the second quarter of 2011, going from $34.0bn at the end of June 2011 to only $7.8bn at the end of March 2012.

Of course, closed deals are also important as an indicator.

Top 10 chem deals Q1 2012

Total dollar volume of chemical M&A worldwide in the first quarter was only $6bn, of which the largest deal was the $1.5bn acquisition of Belgium-based amines producer Taminco by US private equity firm Apollo Management, where we were the financial advisor to Apollo.

This compares to $17bn in closed deals in the fourth quarter of 2011 and a record $82bn for all of 2011. With the first quarter of 2012 at only 7.3% of last year's full year dollar volume and the backlog as of the end of the first quarter at only 9.5% of last year's dollar volume, there is no question that 2012 will fall far short.

How far below will be determined by what happens in ­Europe and in China and whether the availability of high-yield debt stabilizes.

LOW CONFIDENCE

With the surging political rebellion in Europe against austerity measures that has resulted in changes in leadership, the serious economic conditions in Greece and Spain, the ongoing recession in most of the rest of Europe, and the slowdown in growth in China, it is hard to see a sufficient surge in confidence and availability of high-yield financing that will allow 2012 chemical M&A dollar volume to equal 2011.

Chem companies acquisitions

This would require over $78bn of deals to close in the last three quarters of 2012 - an amount equal to 10 times the most recent backlog and 13 times the dollar volume in the first quarter.


Author: Peter Young



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly